Determination of voriconazole in human plasma and saliva using high-performance liquid chromatography with fluorescence detection
Authors:
- 1 April 2008
- journal article
- Published by Elsevier in Journal of Chromatography B
- Vol. 865 (1-2) , 74-80
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Correlation of Neo-Sensitabs Tablet Diffusion Assay Results on Three Different Agar Media with CLSI Broth Microdilution M27-A2 and Disk Diffusion M44-A Results for Testing Susceptibilities of Candida spp. and Cryptococcus neoformans to Amphotericin B, Caspofungin, Fluconazole, Itraconazole, and VoriconazoleJournal of Clinical Microbiology, 2007
- Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose AdministrationAntimicrobial Agents and Chemotherapy, 2004
- THE DISPOSITION OF VORICONAZOLE IN MOUSE, RAT, RABBIT, GUINEA PIG, DOG, AND HUMANDrug Metabolism and Disposition, 2003
- Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal InfectionsClinical Infectious Diseases, 2003
- Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation RegimensAntimicrobial Agents and Chemotherapy, 2002
- Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: a Dose Escalation StudyThe Journal of Clinical Pharmacology, 2002
- In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literatureMycopathologia, 2001
- Voriconazole: A second-generation triazoleDrugs of Today, 2001
- Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatusJournal of Antimicrobial Chemotherapy, 1998
- In vitroactivity of voriconazole against selected fungiMedical Mycology, 1998